TRU - TransUnion
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$94.90
DETAILS
HIGH:
$115.00
LOW:
$77.00
MEDIAN:
$98.00
CONSENSUS:
$94.90
UPSIDE:
14.50%
AlphaVal
Deterministic, archetype-aware fair value
Banks, Insurers & Asset Managers
80% confidence
Primary model: P/Tangible Book × ROE Quality
Adjust Assumptions
10.3%
12.7%
Key Value Driver
ROTCE (10.3%) vs. cost of equity (12.7%)
Implied Market Multiple
3.58x
Plain-Language Summary
With ROTCE of 10.3% vs. 12.7% cost of equity, fair P/TBV is 0.72x on $23.17 tangible book, implying $26.31 per share. DDM cross-check: $6.38.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (27 analysts)
$94.90
Analyst Range
$77.00 – $115.00
Divergence from AlphaVal
72%
Warnings
Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Return on equity (10.3%) is below the minimum investors require (12.7%). This means the bank is worth less than the net assets on its books.
Dividend-based valuation: $6.38 (76% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $94.90 (from 27 analysts). Our estimate is 72% below the consensus -- consider that gap carefully.
Key Risks
- Book value quality matters as much as level — check loan loss reserves
- Interest rate sensitivity creates non-linear earnings surprises
- Insurance reserving is actuarial, not financial — errors emerge slowly